Literature DB >> 8883525

Variability of platelet degranulation by different contrast media.

E F Grabowski1, I K Jang, H Gold, C Head, S E Benoit, A D Michelson.   

Abstract

RATIONALE AND
OBJECTIVES: It has been suggested that nonionic but not ionic contrast media degranulate blood platelets when mixtures of blood and contrast media are studied by flow cytometry. This phenomenon was further assessed in the current study not only by performing whole-blood platelet flow cytometry but also by performing flowing blood platelet aggregometry. The latter is a highly sensitive measure of platelet function.
METHODS: Blood samples were collected from six normal donors and mixed with equal volumes of an ionic monomer (diatrizoate), a nonionic monomer (iohexol), an ionic dimer (ioxaglate), and a nonionic dimer (iodixanol). Samples were collected in the presence of no anticoagulant for 1 min prior to the addition of sodium citrate or in the presence of heparin (14.5 U/ml) or recombinant hirudin (60 micrograms/ml). All samples were fixed in formaldehyde within 30 min.
RESULTS: Platelet degranulation was observed with one nonionic agent (iohexol) and one ionic agent (diatrizoate). Degranulation was not seen with iodixanol or ioxaglate.
CONCLUSION: These findings indicate that degranulation is independent of the ionic or nonionic nature per se of contrast media. A possible explanation for this conclusion is suggested.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883525     DOI: 10.1016/s1076-6332(05)80363-0

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  5 in total

1.  Similar inhibition of platelet adhesion, P-selectin expression and plasma coagulation by ioversol, iodixanol and ioxaglate.

Authors:  J P Fägerstam; A K Ostberg; A C Eriksson; S-G Fransson; P A Whiss
Journal:  Br J Radiol       Date:  2009-06-22       Impact factor: 3.039

Review 2.  Comparative tolerability of contrast media used for coronary interventions.

Authors:  Enrique Esplugas; Angel Cequier; Joan A Gomez-Hospital; Bruno García Del Blanco; Francisco Jara
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Incidence of contrast-induced nephropathy in hospitalised patients with cancer.

Authors:  Irfan Cicin; Bulent Erdogan; Emrah Gulsen; Sernaz Uzunoglu; Necdet Sut; Esma Turkmen; Hilmi Kodaz; Sedat Ustundag
Journal:  Eur Radiol       Date:  2013-09-25       Impact factor: 5.315

4.  Iodixanol Has a Favourable Fibrinolytic Profile Compared to Iohexol in Cardiac Patients Undergoing Elective Angiography: A Double-Blind, Randomized, Parallel Group Study.

Authors:  Andrew T Treweeke; Benjamin H Maskrey; Kirsty Hickson; John H Miller; Stephen J Leslie; Ian L Megson
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

Review 5.  Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?

Authors:  Jolanta Małyszko; Leszek Kozlowski; Klaudia Kozłowska; Maciej Małyszko; Jacek Małyszko
Journal:  Oncotarget       Date:  2017-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.